Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Lipoxygenase pathways in atherogenesis.

Lei Zhao1, Colin D Funk

  • 1Center for Experimental Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6160, USA.

Trends in Cardiovascular Medicine
|July 21, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cardioprotection by Peroxidase Activity of Prostaglandin H Synthases in Ischemia/Reperfusion Injury.

Circulation·2023
Same author

Target Product Profile Analysis of COVID-19 Vaccines in Phase III Clinical Trials and Beyond: An Early 2021 Perspective.

Viruses·2021
Same author

Arginase-1 deficiency in neural cells does not contribute to neurodevelopment or functional outcomes after sciatic nerve injury.

Neurochemistry international·2021
Same author

A Novel Strategy to Mitigate the Hyperinflammatory Response to COVID-19 by Targeting Leukotrienes.

Frontiers in pharmacology·2020
Same author

A Snapshot of the Global Race for Vaccines Targeting SARS-CoV-2 and the COVID-19 Pandemic.

Frontiers in pharmacology·2020
Same author

Perivascular adipose tissue-derived extracellular vesicle miR-221-3p mediates vascular remodeling.

FASEB journal : official publication of the Federation of American Societies for Experimental Biology·2019

The 15-lipoxygenase-1 (15-LO-1) and 5-lipoxygenase (5-LO) pathways are implicated in cardiovascular disease. Further research with new drugs is needed to clarify their exact roles in atherosclerosis.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Research

Background:

  • The 15-lipoxygenase-1 (15-LO-1) and 5-lipoxygenase (5-LO)/5-LO-activating protein (FLAP) pathways are crucial for low-density lipoprotein oxidation and leukotriene biosynthesis.
  • Recent genetic and expression studies suggest a link between the 5-LO/FLAP pathway and human cardiovascular disease.

Purpose of the Study:

  • To investigate the roles of 15-LO-1 and 5-LO/FLAP pathways in the development and progression of cardiovascular disease.
  • To explore the involvement of these lipoxygenase pathways in the inflammatory aspects of atherosclerosis.

Main Methods:

  • Utilized knockout and transgenic mouse models (12/15-LO, 15-LO-1, 5-LO) on atherosclerotic backgrounds.
  • Analyzed gene expression data from human coronary artery disease samples.

Related Experiment Videos

  • Proposed development of novel pharmacologic tools for pathway dissection.

    • Main Results:

    • Experimental studies in mice and human gene expression data suggest a link between 15-LO-1 and 5-LO/FLAP pathways and atherosclerotic progression.
    • Compelling evidence connects these pathways to the etiologic progression of cardiovascular disease.

    Conclusions:

    • The 15-LO-1 and 5-LO/FLAP pathways are significantly involved in cardiovascular disease pathogenesis.
    • Further research, including the development of specific pharmacologic tools, is necessary to resolve conflicting findings and elucidate the precise roles of individual lipoxygenases (LOs) in atherosclerosis.